These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Acute hemodynamic effects during immunoadsorption in patients with dilated cardiomyopathy positive for beta 1-adrenoceptor autoantibodies. Christ T; Dobrev D; Wallukat G; Schüler S; Ravens U Methods Find Exp Clin Pharmacol; 2001 Apr; 23(3):141-4. PubMed ID: 11523313 [TBL] [Abstract][Full Text] [Related]
6. Hemodynamic improvement and removal of autoantibodies against beta1-adrenergic receptor by immunoadsorption therapy in dilated cardiomyopathy. Mobini R; Staudt A; Felix SB; Baumann G; Wallukat G; Deinum J; Svensson H; Hjalmarson A; Fu M J Autoimmun; 2003 Jun; 20(4):345-50. PubMed ID: 12791320 [TBL] [Abstract][Full Text] [Related]
7. Long-term benefits of immunoadsorption in β(1)-adrenoceptor autoantibody-positive transplant candidates with dilated cardiomyopathy. Dandel M; Wallukat G; Englert A; Lehmkuhl HB; Knosalla C; Hetzer R Eur J Heart Fail; 2012 Dec; 14(12):1374-88. PubMed ID: 22892122 [TBL] [Abstract][Full Text] [Related]
8. Immunoadsorption can improve cardiac function in transplant candidates with non-ischemic dilated cardiomyopathy associated with diabetes mellitus. Dandel M; Englert A; Wallukat G; Riese A; Knosalla C; Stein J; Hetzer R Atheroscler Suppl; 2015 May; 18():124-33. PubMed ID: 25936316 [TBL] [Abstract][Full Text] [Related]
9. Removal of cardiodepressant antibodies in dilated cardiomyopathy by immunoadsorption. Felix SB; Staudt A; Landsberger M; Grosse Y; Stangl V; Spielhagen T; Wallukat G; Wernecke KD; Baumann G; Stangl K J Am Coll Cardiol; 2002 Feb; 39(4):646-52. PubMed ID: 11849864 [TBL] [Abstract][Full Text] [Related]
10. Potential role of humoral immunity in cardiac dysfunction of patients suffering from dilated cardiomyopathy. Staudt A; Staudt Y; Dörr M; Böhm M; Knebel F; Hummel A; Wunderle L; Tiburcy M; Wernecke KD; Baumann G; Felix SB J Am Coll Cardiol; 2004 Aug; 44(4):829-36. PubMed ID: 15312867 [TBL] [Abstract][Full Text] [Related]
11. Immunoadsorption in idiopathic dilated cardiomyopathy, a 3-year follow-up. Dörffel WV; Wallukat G; Dörffel Y; Felix SB; Baumann G Int J Cardiol; 2004 Dec; 97(3):529-34. PubMed ID: 15561344 [TBL] [Abstract][Full Text] [Related]
12. Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy. Müller J; Wallukat G; Dandel M; Bieda H; Brandes K; Spiegelsberger S; Nissen E; Kunze R; Hetzer R Circulation; 2000 Feb; 101(4):385-91. PubMed ID: 10653829 [TBL] [Abstract][Full Text] [Related]
13. Immunoadsorption as treatment option in dilated cardiomyopathy. Felix SB; Staudt A Autoimmunity; 2008 Sep; 41(6):484-9. PubMed ID: 18781476 [TBL] [Abstract][Full Text] [Related]
14. Role of immunoglobulin G3 subclass in dilated cardiomyopathy: results from protein A immunoadsorption. Staudt A; Dörr M; Staudt Y; Böhm M; Probst M; Empen K; Plötz S; Maschke HE; Hummel A; Baumann G; Felix SB Am Heart J; 2005 Oct; 150(4):729-36. PubMed ID: 16209975 [TBL] [Abstract][Full Text] [Related]
15. Ig apheresis for the treatment of severe DCM patients. Pokrovsky SN; Ezhov MV; Safarova MS; Saidova MA; Shitov VN; Afanasieva MI; Khaustov AI; Adamova IY; Afanasieva OI; Konovalov GA Atheroscler Suppl; 2013 Jan; 14(1):213-8. PubMed ID: 23357167 [TBL] [Abstract][Full Text] [Related]
16. Immunohistological changes in dilated cardiomyopathy induced by immunoadsorption therapy and subsequent immunoglobulin substitution. Staudt A; Schäper F; Stangl V; Plagemann A; Böhm M; Merkel K; Wallukat G; Wernecke KD; Stangl K; Baumann G; Felix SB Circulation; 2001 Jun; 103(22):2681-6. PubMed ID: 11390337 [TBL] [Abstract][Full Text] [Related]
17. Non-specific immunoadsorption in patients with dilated cardiomyopathy: mechanisms and clinical effects. Felix SB; Staudt A Int J Cardiol; 2006 Sep; 112(1):30-3. PubMed ID: 16860418 [TBL] [Abstract][Full Text] [Related]